ACELYRIN, INC. Alternatives & Competitors
12 companies similar to ACELYRIN, INC. — We are a late-stage clinical biopharma company focused on providing life-changin...
Companies similar to ACELYRIN, INC.
3T Biosciences
3T is an immunotherapy company developing next-generation, transformative therapies for br...
South San Francisco, Unit...
Eidos Therapeutics
Pioneering genetically targeted therapies to swiftly translate breakthrough science into l...
Pharvaris
Pioneering science for patient choice
Zug, Switzerland
Rival Readout
Competing with ACELYRIN, INC.? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
VectivBio
Biotech company develops treatments for severe rare diseases, aims to become global leader...
Basel, Switzerland
Cytokinetics
Empowering Muscle Empowering Lives
South San Francisco, Unit...
Dyne Therapeutics
Advancing life-transforming therapies for serious muscle diseases
Waltham, United States
Alumis
Transforming the lives of patients living with immune-mediated diseases using a precision...
South San Francisco, Unit...
Capstan Therapeutics
Advancing cell engineering to develop therapeutics for a broad range of diseases
Bedford, United States
Tvardi Therapeutics
Breakthrough Medicines for Cancer, Chronic Inflammation & Fibrosis
Houston, United States
About ACELYRIN, INC.
ACELYRIN, INC. is a biopharmaceutical company headquartered in the United States with operations in the Los Angeles and San Francisco Bay areas. Founded in 2020, the company is strategically positioned in the Biopharma, Biotechnology, and Health Care industries, focusing on late-stage clinical development.
therapy development, research and development, clinical trial management, data analytics for drug development, patient resource provision
patients with immune-mediated diseases, healthcare providers, pharmaceutical investors, medical researchers, biotech stakeholders
Late-stage Clinical Biopharma, Patient-focused, Life-changing Treatment Options, Drug Acquisition, Development Acceleration, Commercialization, Courageous Caring, Disease Treatment, Product Candidate Identification, Biopharmaceutical Expertise, Medicine Advancement, Corporate Culture
B2B, B2C, B2D
Product Sales, Licensing
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around ACELYRIN, INC.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at ACELYRIN, INC. on 28 Jan 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
